The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Pain-Induced Negative Affect Is Mediated via Recruitment of The Nucleus Accumbens Kappa Opioid System
Open accessAbstract
Negative affective states affect quality of life for patients suffering from pain. These maladaptive emotional states can lead to involuntary opioid overdose and many neuropsychiatric comorbidities. Uncovering the mechanisms responsible for pain-induced negative affect is critical in addressing these comorbid outcomes. The nucleus accumbens (NAc) shell, which integrates the aversive and rewarding valence of stimuli, exhibits plastic adaptations in the presence of pain. In discrete regions of the NAc, activation of the kappa opioid receptor (KOR) decreases the reinforcing properties of rewards and induces aversive behaviors. Using complementary techniques, we report that in vivo recruitment of NAc shell dynorphin neurons, acting through KOR, is necessary and sufficient to drive pain-induced negative affect. Taken together, our results provide evidence that pain-induced adaptations in the kappa opioid system within the NAc shell represent a functional target for therapeutic intervention that could circumvent pain-induced affective disorders. VIDEO ABSTRACT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The dynorphin/k-opioid receptor system may also be engaged in negative emotional states that are associated with chronic pain (Cahill et al., 2014;Massaly et al., 2016Massaly et al., , 2019)).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Massaly et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The local infusion of microgram amounts of the k-opioid receptor antagonist nor-BNI into the ventral NAc shell blocked conditioned place aversion and the lower motivation to self-administer sucrose that was produced by inflammation (Massaly et al., 2019).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Massaly et al., 2019
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Indeed, in a study of chronic inflammatory pain that was induced by a hindpaw injection of Complete Freund's Adjuvant, dynorphin expression increased in dynorphin-containing neurons in a discrete subregion of the NAc shell through a disinhibition mechanism, and pain increased k-opioid receptor function (Massaly et al., 2019).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Massaly et al., 2019
The cited source says what the claim attributes to it.
In the citing paper
“Even more compelling, using a series of pharmacological, optogenetic, and chemogenetic approaches, the authors showed that both dynorphin-containing neurons and k-opioid receptor activity in the NAc shell were necessary and sufficient to drive pain-induced negative affective states (Massaly et al., 2019).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Massaly et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466
(2012) · doi:10.1016/j.jmoldx.2011.08.002 · Cited by 2,567
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Roth, B. L. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.040 · Cited by 1,742
Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies
Volkow, N. D., & McLellan, A. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1507771 · Cited by 1,366
A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor
Elias, W. J., Lipsman, N., Ondo, W. G., Ghanouni, P., Kim, Y. G., Lee, W., Schwartz, M., Hynynen, K., Lozano, A. M., Shah, B. B., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600159 · Cited by 1,167
CRH Engagement of the Locus Coeruleus Noradrenergic System Mediates Stress-Induced Anxiety
McCall, J. G., Al-Hasani, R., Siuda, E. R., Hong, D. Y., Norris, A. J., Ford, C. P., & Bruchas, M. R. (2015) · Neuron · doi:10.1016/j.neuron.2015.07.002 · Cited by 666
Self-citationAn excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger
Krashes, M. J., Shah, B. P., Madara, J. C., Olson, D. P., Strochlic, D. E., Garfield, A. S., Vong, L., Pei, H., Watabe-Uchida, M., Uchida, N., et al. (2014) · Nature · doi:10.1038/nature12956 · Cited by 603
The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System
Land, B. B., Bruchas, M. R., Lemos, J. C., Xu, M., Melief, E. J., & Chavkin, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4458-07.2008 · Cited by 601
Self-citationThe dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors
Bruchas, M. R., Land, B. B., & Chavkin, C. (2010) · Brain Research · doi:10.1016/j.brainres.2009.08.062 · Cited by 544
Self-citation
Cited by
Sorted by citations
Neurobiology of opioid addiction: Opponent process, hyperkatifeia, and negative reinforcement
Koob, G. F. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.023 · Cited by 477
Cellular Circuits in the Brain and Their Modulation in Acute and Chronic Pain
Kuner, R., & Kuner, T. (2020) · Physiological Reviews · doi:10.1152/physrev.00040.2019 · Cited by 371
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Castro, D. C., & Bruchas, M. R. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.003 · Cited by 306
Self-citationBrain circuits for pain and its treatment
Lindsay, N. M., Chen, C., Gilam, G., Mackey, S., & Scherrer, G. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj7360 · Cited by 246
Amygdala, neuropeptides, and chronic pain-related affective behaviors
Neugebauer, V., Mazzitelli, M., Cragg, B., Ji, G., Navratilova, E., & Porreca, F. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108052 · Cited by 220
Innovations and advances in modelling and measuring pain in animals
Sadler, K. E., Mogil, J. S., & Stucky, C. L. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00536-7 · Cited by 199
Klawonn, A. M., Fritz, M., Castany, S., Pignatelli, M., Canal, C., Similä, F., Tejeda, H. A., Levinsson, J., Jaarola, M., Jakobsson, J., et al. (2021) · Immunity · doi:10.1016/j.immuni.2020.12.016 · Cited by 163
Sex differences in neuroimmune and glial mechanisms of pain
Gregus, A. M., Levine, I. S., Eddinger, K. A., Yaksh, T. L., & Buczynski, M. W. (2021) · Pain · doi:10.1097/j.pain.0000000000002215 · Cited by 137
Pain induces adaptations in ventral tegmental area dopamine neurons to drive anhedonia-like behavior
Markovic, T., Pedersen, C. E., Massaly, N., Vachez, Y. M., Ruyle, B. C., Murphy, C. A., Abiraman, K., Shin, J. H., Garcia, J. J., Yoon, H. J., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00924-3 · Cited by 129
Self-citationSong, Q., Wei, A., Xu, H., Gu, Y., Jiang, Y. Q., Dong, N., Zheng, C., Wang, Q., Gao, M., Sun, S., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-023-01519-w · Cited by 133
Current status of opioid addiction treatment and related preclinical research
Kreek, M. J., Reed, B., & Butelman, E. R. (2019) · Science Advances · doi:10.1126/sciadv.aax9140 · Cited by 111
Evidence and explanation for the involvement of the nucleus accumbens in pain processing
Harris, H. N., & Peng, Y. B. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.266909 · Cited by 108
Reward and aversion processing by input-defined parallel nucleus accumbens circuits in mice
Zhou, K., Xu, H. Z., Lu, S., Jiang, S., Hou, G., Deng, X., He, M., & Zhu, Y. (2022) · Nature Communications · doi:10.1038/s41467-022-33843-3 · Cited by 118
An endogenous opioid circuit determines state-dependent reward consumption
Castro, D. C., Oswell, C. S., Zhang, E. T., Pedersen, C. E., Piantadosi, S. C., Rossi, M. A., Hunker, A. C., Guglin, A., Morón, J. A., Zweifel, L. S., et al. (2021) · Nature · doi:10.1038/s41586-021-04013-0 · Cited by 95
Self-citationLoss of nucleus accumbens low-frequency fluctuations is a signature of chronic pain
Makary, M. M., Polosecki, P. I., Cecchi, G., DeAraujo, I. E., Barron, D. S., Constable, R. T., Whang, P. G., Thomas, D.-A. M., Mowafi, H. O., Small, D. M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1918682117 · Cited by 96
Endogenous opioid systems alterations in pain and opioid use disorder
Higginbotham, J. A., Markovic, T., Massaly, N., & Morón, J. A. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.1014768 · Cited by 94
Self-citationAnhedonia, Hyperkatifeia, and Negative Reinforcement in Substance Use Disorders
Koob, G. F. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_288 · Cited by 92
Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal
Pomrenze, M. B., Pinto, D. F. C., Neumann, P. A., Llorach, P., Tucciarone, J., Morishita, W., Eshel, N., Heifets, B. D., & Malenka, R. C. (2022) · Neuron · doi:10.1016/j.neuron.2022.09.024 · Cited by 79
Pantazis, C. B., Gonzalez, L. A., Tunstall, B. J., Carmack, S. A., Koob, G. F., & Vendruscolo, L. F. (2021) · Science Advances · doi:10.1126/sciadv.abf0364 · Cited by 74
Central amygdala circuits in valence and salience processing
Kong, M.-S., & Zweifel, L. S. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113355 · Cited by 86
Emery, M. A., & Akil, H. (2020) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-110719-095912 · Cited by 56
Paton, K. F., Atigari, D. V., Kaska, S., Prisinzano, T. E., & Kivell, B. M. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000134 · Cited by 61
Pignatelli, M., Tejeda, H. A., Barker, D. J., Bontempi, L., Wu, J., Lopez, A., Ribeiro, S. P., Lucantonio, F., Parise, E. M., Torres‐Berrío, A., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0686-8 · Cited by 60
From Pleasure to Pain, and Back Again: The Intricate Relationship Between Alcohol and Nociception
Robins, M. T., Heinricher, M. M., & Ryabinin, A. E. (2019) · Alcohol and Alcoholism · doi:10.1093/alcalc/agz067 · Cited by 63
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion
Margolis, E. B., & Karkhanis, A. N. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104504 · Cited by 56
Kerekes, N., Sánchez‐Pérez, A. M., & Landry, M. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110717 · Cited by 53
Reward processing as a common diathesis for chronic pain and depression
Rizvi, S. J., Gandhi, W., & Salomons, T. V. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.04.033 · Cited by 50
Chakraborty, S., Uprety, R., Daibani, A. E., Rouzic, V. L., Hunkele, A., Appourchaux, K., Eans, S. O., Nuthikattu, N., Jilakara, R., Thammavong, L., et al. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00149 · Cited by 45
Reduced nucleus accumbens enkephalins underlie vulnerability to social defeat stress
Nam, H., Chandra, R., Francis, T. C., Dias, C., Cheer, J. F., & Lobo, M. K. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0422-8 · Cited by 51
The role of P2X4 receptors in chronic pain: A potential pharmacological target
Zhang, W., Luo, H., & Zhu, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110447 · Cited by 44
Ito, H., Navratilova, E., Vagnerova, B., Watanabe, M., Kopruszinski, C. M., de Souza, L. H. M., Yue, X., Ikegami, D., Moutal, A., Patwardhan, A. M., et al. (2022) · Brain · doi:10.1093/brain/awac153 · Cited by 42
Neuropathic Pain Dysregulates Gene Expression of the Forebrain Opioid and Dopamine Systems
Wawrzczak‐Bargieła, A., Ziółkowska, B., Piotrowska, A., Starnowska-Sokół, J., Rojewska, E., Mika, J., Przewłocka, B., & Przewłocki, R. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00166-4 · Cited by 40
Dissecting the Neural Circuitry for Pain Modulation and Chronic Pain: Insights from Optogenetics
Guo, F., Du, Y., Qu, F.-H., Lin, S.-D., Chen, Z., & Zhang, S. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00835-8 · Cited by 44
Burek, D., Massaly, N., Yoon, H. J., Doering, M. M., & Morón, J. A. (2021) · Pain · doi:10.1097/j.pain.0000000000002467 · Cited by 41
Self-citationZiółkowska, B. (2021) · Brain Sciences · doi:10.3390/brainsci11101311 · Cited by 41
Ibrahim, K. M., Massaly, N., Yoon, H. J., Sandoval, R., Widman, A. J., Heuermann, R. J., Williams, S. B., Post, W., Pathiranage, S., Lintz, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44836-9 · Cited by 41
Self-citationPain-related cortico-limbic plasticity and opioid signaling
Neugebauer, V., Presto, P., Yakhnitsa, V., Antenucci, N., Mendoza, B., & Ji, G. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109510 · Cited by 38
Factors mediating pain-related risk for opioid use disorder
Nazarian, A., Negus, S. S., & Martin, T. J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108476 · Cited by 35
Optogenetics and its application in pain and anxiety research
Jarrin, S., & Finn, D. P. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.08.007 · Cited by 34
Greis, A. C., Larsen, E., Liu, C., Renslo, B., Radakrishnan, A., & Wilson‐Poe, A. R. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0088 · Cited by 34
Self-citationKo, M. J., Chiang, T., Mukadam, A. A., Mulia, G. E., Gutridge, A. M., Lin, A., Chester, J. A., & van Rijn, R. M. (2021) · Science Signaling · doi:10.1126/scisignal.aba0245 · Cited by 34
French, A. R., & van Rijn, R. M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106091 · Cited by 32
Potential for Kappa-Opioid Receptor Agonists to Engineer Nonaddictive Analgesics: A Narrative Review
Kaski, S. W., White, A., Gross, J., & Siderovski, D. P. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005309 · Cited by 32
A neural circuit for the suppression of feeding under persistent pain
Tang, H.-D., Dong, W., Hu, R. M., Huang, J.-Y., Huang, Z., Xiong, W., Xue, T., Liu, J., Yu, J., Zhu, X., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00688-5 · Cited by 35
Engaging endogenous opioid circuits in pain affective processes
Kimmey, B. A., McCall, N. M., Wooldridge, L. M., Satterthwaite, T. D., & Corder, G. F. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24762 · Cited by 31
κ-Opioid receptor antagonism reverses heroin withdrawal-induced hyperalgesia in male and female rats
Marchette, R. C. N., Gregory‐Flores, A., Tunstall, B. J., Carlson, E. R., Jackson, S. N., Sulima, A., Rice, K. C., Koob, G. F., & Vendruscolo, L. F. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100325 · Cited by 31
Cocaine-induced neuron subtype mitochondrial dynamics through Egr3 transcriptional regulation
Cole, S. L., Chandra, R., Harris, M., Patel, I., Wang, T., Kim, H.-J., Jensen, L., Russo, S. J., Turecki, G., Gancarz, A. M., et al. (2021) · Molecular Brain · doi:10.1186/s13041-021-00800-y · Cited by 28
Neuropeptides Modulate Feeding via the Dopamine Reward Pathway
Jin, R., Sun, S., Hu, Y., Zhang, H., & Sun, X. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03954-4 · Cited by 26
Schindler, A. G., Baskin, B. M., Juarez, B., Lee, S. J., Hendrickson, R. C., Pagulayan, K. F., Zweifel, L. S., Raskind, M. A., Phillips, P. E. M., Peskind, E. R., et al. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14605 · Cited by 26
Wang, H., Flores, R. J., Yarur, H. E., Limoges, A., Bravo-Rivera, H., Casello, S. M., Loomba, N., Enríquez-Traba, J., Arenivar, M. A., Wang, Q., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.03.015 · Cited by 25
Vergara, F., Sardi, N. F., Pescador, A. C., Guaita, G. O., Stern, C. A. J., Chichorro, J. G., & Fischer, L. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108226 · Cited by 25
Allostasis theory in opioid tolerance
Ballantyne, J. C., & Koob, G. F. (2021) · Pain · doi:10.1097/j.pain.0000000000002280 · Cited by 25
Basu, P., Custodio-Patsey, L., Prasoon, P., Smith, B. N., & Taylor, B. K. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2622-20.2021 · Cited by 25
Nakamoto, K., Taniguchi, A., & Tokuyama, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173173 · Cited by 25
Wu, X., Zhu, Q., & Gao, Y. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00697-6 · Cited by 23
Opioid signaling and design of analgesics
Paul, B., Sribhashyam, S., & Majumdar, S. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.017 · Cited by 41
Neural circuits provide insights into reward and aversion
Chen, W. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.1002485 · Cited by 28
The Operant Plantar Thermal Assay: A Novel Device for Assessing Thermal Pain Tolerance in Mice
Reker, A. N., Chen, S., Etter, K., Burger, T., Caudill, M., & Davidson, S. (2020) · eNeuro · doi:10.1523/eneuro.0210-19.2020 · Cited by 23
Massaly, N., Temp, J., Machelska, H., & Stein, C. (2020) · Pain · doi:10.1097/j.pain.0000000000001968 · Cited by 21
Self-citationAdvances in the Treatment of Chronic Pain by Targeting GPCRs
Che, T. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00644 · Cited by 21
Effects of inflammatory pain on CB1 receptor in the midbrain periaqueductal gray
Wilson‐Poe, A. R., Wiese, B. M., Kibaly, C., Lueptow, L. M., Garcia, J. J., Anand, P., Cahill, C. M., & Morón, J. A. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000897 · Cited by 20
Self-citationLorente, J. D., Cuitavi, J., Campos‐Jurado, Y., Montón-Molina, R., González-Romero, J. L., & Hipólito, L. (2021) · Pain · doi:10.1097/j.pain.0000000000002332 · Cited by 19
Self-citationFontaine, H. M., Silva, P. R., Neiswanger, C., Tran, R., Abraham, A. D., Land, B. B., Neumaier, J. F., & Chavkin, C. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01178-0 · Cited by 24
Wu, X., Zhu, Q., Gao, M.-H., Yan, S.-X., Gu, P.-Y., Zhang, P., Xu, M., & Gao, Y. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1359-22.2023 · Cited by 22
Legakis, L. P., Karim-Nejad, L., & Negus, S. S. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05530-y · Cited by 20
Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine
Cameron, C. M., Nieto, S. J., Bosler, L., Wong, M. H., Bishop, I., Mooney, L. J., & Cahill, C. M. (2021) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2021.10009 · Cited by 20
Self-citationInsights into the Neurobiology of Craving in Opioid Use Disorder
Lueptow, L. M., Shashkova, E., Miller, M. G., Evans, C. J., & Cahill, C. M. (2020) · Current anesthesiology reports · doi:10.1007/s40140-020-00420-7 · Cited by 20
Self-citationCosta, A. R., Tavares, I., & Martins, I. (2023) · Pain · doi:10.1097/j.pain.0000000000003026 · Cited by 18
Targeting Prefrontal Cortex Dysfunction in Pain
Kummer, K. K., & Sheets, P. L. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.002046 · Cited by 20
Xu, X., Wu, K., Ma, X., Wang, W., Wang, H., Huang, M., Luo, L., Su, C., Yuan, T., Shi, H., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02469-9 · Cited by 17
Wang, C., Chen, M., Qin, C., Qu, X., Shen, X., & Liu, S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.812035 · Cited by 18
Self-citationJi, M., Yang, J., Gao, Z., Zhang, L., & Liu, C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.642493 · Cited by 17
Endogenous opiates and behavior: 2019
Bodnar, R. J. (2021) · Peptides · doi:10.1016/j.peptides.2021.170547 · Cited by 19
Modifying naloxone to reverse fentanyl-induced overdose
Voronkov, M. V., Nikonov, G., Ataiants, J., Isakulyan, L., Ştefănuţ, C., CERNEA, M. S., & Abernethy, J. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121326 · Cited by 17
Jing, P.-B., Chen, X.-H., Lu, H.-J., Gao, Y., & Wu, X. (2022) · Molecular Pain · doi:10.1177/17448069211053255 · Cited by 17
The role of kappa opioid receptors in immune system – An overview
Szczepaniak, A., Machelak, W., Fichna, J., & Zielińska, M. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175214 · Cited by 17
Kappa opioid receptor modulation of endometriosis pain in mice
Escudero-Lara, A., Cabañero, D., & Maldonado, R. J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108677 · Cited by 17
Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development
Aldrich, J. V., & McLaughlin, J. P. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_519 · Cited by 17
Burek, D., Massaly, N., Doering, M. M., Zec, A., Gaelen, J. I., & Morón, J. A. (2021) · Pain · doi:10.1097/j.pain.0000000000002179 · Cited by 18
Self-citationKelley, A. M., Valle, E. J. D., Zaman, S., & Karkhanis, A. N. (2023) · Pain · doi:10.1097/j.pain.0000000000003097 · Cited by 16
Kappa opioid receptors mediate an initial aversive component of paclitaxel-induced neuropathy
Meade, J. A., Alkhlaif, Y., Contreras, K. M., Obeng, S., Toma, W. B., Sim‐Selley, L. J., Selley, D. E., & Damaj, M. I. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05572-2 · Cited by 16
Limitations and potential of κOR biased agonists for pain and itch management
Daibani, A. E., Madasu, M. K., Al‐Hasani, R., & Che, T. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110061 · Cited by 17
Self-citationNeural alterations in opioid-exposed infants revealed by edge-centric brain functional networks
Jiang, W., Merhar, S. L., Zeng, Z., Zhu, Z., Yin, W., Zhou, Z., Wang, L., He, L., Vannest, J. J., & Lin, W. (2022) · Brain Communications · doi:10.1093/braincomms/fcac112 · Cited by 15
Liu, S., Pickens, S. R., Barta, Z., Rice, M., Dagher, M., Lebens, R., Nguyen, T. V., Cummings, B. J., & Cahill, C. M. (2023) · Pain · doi:10.1097/j.pain.0000000000003084 · Cited by 15
Self-citationSpared nerve injury decreases motivation in long-access homecage-based operant tasks in mice
Norris, M. R., Becker, L. J., Bilbily, J., Chang, Y. A., Borges, G., Dunn, S. S., Madasu, M. K., Vazquez, C. R., Cariello, S. A., Al‐Hasani, R., et al. (2023) · Pain · doi:10.1097/j.pain.0000000000003123 · Cited by 15
Self-citationBest, K. M., Mojena, M., Barr, G. A., Schmidt, H. D., & Cohen, A. S. (2021) · Journal of Neurotrauma · doi:10.1089/neu.2021.0063 · Cited by 14
Wei, N., Guo, Z., Ye, R., Guan, L., Ren, J., Liang, Y., Shao, X., Fang, J., Fang, J., & Du, J. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.02.015 · Cited by 14
Lorente, J. D., Cuitavi, J., Rullo, L., Candeletti, S., Romualdi, P., & Hipólito, L. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109764 · Cited by 14
Self-citationMindaye, S. A., Chen, W.-H., Lin, S.-C., Chen, Y.-C., Abdelaziz, M. A., Tzeng, Y.-S., Shih, A. C.-C., Chen, S.-Y., Yang, S., & Chen, C. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114946 · Cited by 13
Jiang, L., Hao, J., Yang, X., Zhu, J., Wang, Y., Huang, Y., Sun, Y., Mao, Y., Ni, K., Gu, X., et al. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03731-9 · Cited by 13
Campos‐Jurado, Y., Lorente, J. D., González-Romero, J. L., Granero, L. M., Polache, A., & Hipólito, L. (2020) · Pain · doi:10.1097/j.pain.0000000000001915 · Cited by 13
Self-citationPain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease
Parker, K. E., Sugiarto, E., Taylor, A. M. W., Pradhan, A. A. A., & Al‐Hasani, R. (2020) · Molecular Pharmacology · doi:10.1124/mol.120.119438 · Cited by 14
Self-citationLorente, J. D., Cuitavi, J., Campos‐Jurado, Y., & Hipólito, L. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24703 · Cited by 13
Self-citationZhang, Y.-N., Xing, X., Chen, L., Dong, X., Pan, H., Hua, X., & Wang, K. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.843815 · Cited by 12
Neuropeptide and cytokine regulation of pain in the context of substance use disorders
Delery, E., & Edwards, S. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108153 · Cited by 12
Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction
Cahill, C. M., Lueptow, L. M., Kim, H., Shusharla, R., Bishop, A., & Evans, C. J. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_434 · Cited by 12
Self-citationSaito, H., Hidema, S., Otsuka, A., Suzuki, J., Kumagai, M., Kanaya, A., Murakami, T., Takei, Y., Saito, K., Sugino, S., et al. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.08.042 · Cited by 12
Lee, S. J., Logsdon, A. F., Yagi, M., Baskin, B. M., Peskind, E. R., Raskind, M. M., Cook, D. G., & Schindler, A. G. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02643-3 · Cited by 11
Wu, S., Jiang, J., Wang, D., Lin, D., Lin, M., Chen, P., Chen, J., Zhang, H., Wang, Y., Chen, X., et al. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111218 · Cited by 12
Metadata
- Authors
- Massaly, N., Copits, B. A., Wilson-Poe, A. R., Hipólito, L., Markovic, T., Yoon, H. J., Liu, S., Walicki, M. C., Bhatti, D. L., Sirohi, S., Klaas, A., Walker, B. M., Neve, R., Cahill, C. M., Shoghi, K. I., Gereau, R. W., McCall, J. G., Al-Hasani, R., Bruchas, M. R., & Morón, J. A.
- Affiliations
- Washington University in St. Louis (US)
- University of California, Los Angeles (US)
- University of Health Sciences and Pharmacy (US)
- Washington State University (US)
- Massachusetts Institute of Technology (US)
- Corresponding author
- Bruchas, Michael R.
- ORCID
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 102
- Issue
- 3
- Pages
- 564-573.e6
- ISSN
- 0896-6273 (ISSN-L)
- PMC
- PMC6509001
- OpenAlex
- W2922000881
- Cited by
- 200
- References
- 45
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 21 · 2023: 16 · 2022: 27 · 2021: 49 · 2020: 28 · 2019: 12
- FWCI
- 13.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (DA041781, DA042581, DA042499, DA041883, DA045463)
- Brain and Behavior Research Foundation (DA033396, DA037152, R01-NS106953, AA020394, K99/R00-DA038725, K99-DA041467)
- Philippe Foundation
- Mallinckrodt Institute of Radiology at Washington University (16-014)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nucleus accumbens shell, kappa opioid receptor, opioid overdose, aversive behavior, reward processing
- MeSH terms
- Affect, Animals, Dynorphins, Inflammation, Neural Inhibition, Neuronal Plasticity, Neurons, Nucleus Accumbens, Pain, Receptors, Opioid, kappa, Mood Disorders, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
